Drug class
Antipsychotic Benzamides
Antipsychotic benzamides, commonly referred to in clinical psychopharmacology as substituted benzamides, are a distinct chemical and pharmacologic subgroup of antipsychotic agents that include compounds such as amisulpride, sulpiride, and tiapride. Read more about Antipsychotic Benzamides
1 drugs in this class 1 manufacturers
Drugs in Antipsychotic Benzamides
Antipsychotic benzamides, commonly referred to in clinical psychopharmacology as substituted benzamides, are a distinct chemical and pharmacologic subgroup of antipsychotic agents that include compounds such as amisulpride, sulpiride, and tiapride.
They primarily exert their therapeutic effects through selective antagonism of central dopamine D2 and D3 receptors, demonstrating notable limbic selectivity and minimal affinity for cholinergic, histaminergic, or adrenergic receptors compared to other traditional antipsychotic classes.
Therapeutically, these agents are used predominantly in the management of schizophrenia and other psychotic disorders, with lower doses sometimes utilized for mood or dysthymic conditions and hyperkinetic movement disorders.
-
farmaciajournal.com
Antipsychotic benzamides, commonly referred to in clinical psychopharmacology as substituted benzamides, are a distinct chemical and pharmacologic subgroup of antipsychotic agents that include compounds such as amisulpride, sulpiride, and tiapride They primarily exert their therapeutic effects through selective antagonism of central dopamine D2 and D3 receptors, demonstrating notable limbic selectivity and minimal affinity for cholinergic, histaminergic, or adrenergic receptors compared to other...
-
wikipedia.org
Antipsychotic benzamides, commonly referred to in clinical psychopharmacology as substituted benzamides, are a distinct chemical and pharmacologic subgroup of antipsychotic agents that include compounds such as amisulpride, sulpiride, and tiapride They primarily exert their therapeutic effects through selective antagonism of central dopamine D2 and D3 receptors, demonstrating notable limbic selectivity and minimal affinity for cholinergic, histaminergic, or adrenergic receptors compared to other...
-
nih.gov
They primarily exert their therapeutic effects through selective antagonism of central dopamine D2 and D3 receptors, demonstrating notable limbic selectivity and minimal affinity for cholinergic, histaminergic, or adrenergic receptors compared to other traditional antipsychotic classes
-
youtube.com
Therapeutically, these agents are used predominantly in the management of schizophrenia and other psychotic disorders, with lower doses sometimes utilized for mood or dysthymic conditions and hyperkinetic movement disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.